Sayre Therapeutics
A healthcare organisation in the business of commercialising novel medicines, medical devices and molecular diagnostics in Oncology.
| Date | Investors | Amount | Round |
|---|---|---|---|
$8.0m | Early VC | ||
| Total Funding | 000k | ||
Related Content
Sayre Therapeutics specializes in providing novel oncology drugs, devices, and molecular diagnostics, focusing on niche products and orphan medications in areas with high unmet needs. The company operates in the healthcare sector, primarily targeting cancer and immune-mediated diseases. Sayre Therapeutics serves healthcare providers, hospitals, and clinics in South Asia, offering solutions such as small molecules, recombinant proteins, and monoclonal antibodies. The business model revolves around the accelerated introduction of healthcare innovations, aiming to improve patient outcomes and quality of life. Revenue is generated through the sale of these specialized medical products and diagnostic solutions.
Keywords: oncology, immunology, niche products, orphan medications, molecular diagnostics, small molecules, recombinant proteins, monoclonal antibodies, healthcare innovations, South Asia.